Saturday, 25 June 2011

Helvepedin




Helvepedin may be available in the countries listed below.


Ingredient matches for Helvepedin



Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Helvepedin in the following countries:


  • Switzerland

International Drug Name Search

Menbit




Menbit may be available in the countries listed below.


Ingredient matches for Menbit



Alprazolam

Alprazolam is reported as an ingredient of Menbit in the following countries:


  • Japan

International Drug Name Search

Tuesday, 21 June 2011

Trosifen




Trosifen may be available in the countries listed below.


Ingredient matches for Trosifen



Ibuprofen

Ibuprofen is reported as an ingredient of Trosifen in the following countries:


  • Colombia

International Drug Name Search

Diprosone




In the US, Diprosone (betamethasone topical) is a member of the drug class topical steroids and is used to treat Atopic Dermatitis, Dermatitis, Dermatological Disorders, Lichen Planus and Lichen Sclerosus.

US matches:

  • Diprosone

UK matches:

  • Diprosone Cream (SPC)
  • Diprosone Lotion (SPC)
  • Diprosone Ointment (SPC)

Ingredient matches for Diprosone



Betamethasone

Betamethasone is reported as an ingredient of Diprosone in the following countries:


  • Tunisia

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Diprosone in the following countries:


  • Argentina

  • Australia

  • Bahrain

  • Belgium

  • Brazil

  • Bulgaria

  • Canada

  • Colombia

  • Czech Republic

  • Ethiopia

  • France

  • Germany

  • Hong Kong

  • Indonesia

  • Ireland

  • Israel

  • Italy

  • Kenya

  • Luxembourg

  • Malaysia

  • Malta

  • Netherlands

  • New Zealand

  • Oman

  • Peru

  • Philippines

  • Poland

  • Portugal

  • Singapore

  • Slovenia

  • South Africa

  • Switzerland

  • Taiwan

  • Thailand

  • United Kingdom

  • Venezuela

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 15 June 2011

Temol




Temol may be available in the countries listed below.


Ingredient matches for Temol



Paracetamol

Paracetamol is reported as an ingredient of Temol in the following countries:


  • Vietnam

International Drug Name Search

Monday, 13 June 2011

Télébrix




Télébrix may be available in the countries listed below.


Ingredient matches for Télébrix



Ioxitalamic Acid

Ioxitalamic Acid meglumine and sodium salt (a derivative of Ioxitalamic Acid) is reported as an ingredient of Télébrix in the following countries:


  • France

  • Tunisia

International Drug Name Search

Monday, 6 June 2011

BI-Sifrol




BI-Sifrol may be available in the countries listed below.


Ingredient matches for BI-Sifrol



Pramipexole

Pramipexole dihydrochloride monohydrate (a derivative of Pramipexole) is reported as an ingredient of BI-Sifrol in the following countries:


  • Japan

International Drug Name Search

Friday, 3 June 2011

Colazal


Colazal is a brand name of balsalazide, approved by the FDA in the following formulation(s):


COLAZAL (balsalazide disodium - capsule; oral)



  • Manufacturer: SALIX PHARMS

    Approval date: July 18, 2000

    Strength(s): 750MG [RLD][AB]

Has a generic version of Colazal been approved?


A generic version of Colazal has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Colazal and have been approved by the FDA:


balsalazide disodium capsule; oral



  • Manufacturer: APOTEX INC

    Approval date: December 28, 2007

    Strength(s): 750MG [AB]


  • Manufacturer: MYLAN

    Approval date: December 28, 2007

    Strength(s): 750MG [AB]


  • Manufacturer: ROXANE

    Approval date: December 28, 2007

    Strength(s): 750MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Colazal. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
    Patent 7,452,872
    Issued: November 18, 2008
    Inventor(s): Johnson; Lorin
    Assignee(s): Salix Pharmaceuticals, Inc.
    A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of balsalazide in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
    Patent expiration dates:

    • August 24, 2026
      ✓ 
      Patent use: TREATMENT OF ULCERATIVE COLITIS


    • February 24, 2027
      ✓ 
      Pediatric exclusivity




  • Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
    Patent 7,625,884
    Issued: December 1, 2009
    Inventor(s): Johnson; Lorin
    Assignee(s): Salix Pharmaceuticals, Ltd
    A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of balsalazide in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
    Patent expiration dates:

    • August 24, 2026
      ✓ 
      Patent use: TREATMENT OF ULCERATIVE COLITIS


    • February 24, 2027
      ✓ 
      Pediatric exclusivity



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • December 20, 2013 - ORPHAN DRUG EXCLUSIVITY

    • June 20, 2014 - PEDIATRIC EXCLUSIVITY

See also...

  • Colazal Consumer Information (Wolters Kluwer)
  • Colazal Consumer Information (Cerner Multum)
  • Colazal Advanced Consumer Information (Micromedex)
  • Colazal AHFS DI Monographs (ASHP)
  • Balsalazide Consumer Information (Wolters Kluwer)
  • Balsalazide Consumer Information (Cerner Multum)
  • Balsalazide Advanced Consumer Information (Micromedex)
  • Balsalazide Disodium AHFS DI Monographs (ASHP)